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Dengue shock syndrome is the most severe form of Dengue that can be fatal. Nonresponders to standard therapy need intensive
care.Thispaperoutlinestheclinicalfeatures,complications,andoutcomesofDengueShockSyndromenotrespondingtostandard
therapies and needing supportive care in a tertiary referral intensive care unit of a developing country. Nearly one-third die within
3 days of admission to ICU. Peritoneal dialysis predicts the worst outcomes.
1.Introduction
Dengue is an important arthropod-borne viral disease of
humans [1]. Its presentation varies from a mild viral
syndrome to hemorrhagic fever and severe shock. Its severe
forms (hemorrhagic fever and shock syndrome) may lead to
multiorganinvolvementanddeath.DengueShockSyndrome
(DSS) is characterized by a massive increase in systemic
capillarypermeabilitywithconsequenthypovolemia[2].The
mortality rate in Dengue Shock Syndrome ranges from 6
to 30 percent, most commonly reported in children. Fluid
resuscitation is critical with added support for failing organs
[3].
In the recent past, Sri Lanka has experienced a surge of
the disease reaching epidemic proportions associated with a
probable change in the virus strain to a more virulent form
[4, 5]. In this context we have also noted a rise in the number
of cases with severe forms of the disease needing intensive
care. The Peradeniya ICU is a tertiary referral centre and it
attracts a large number of above patients with Dengue Shock
Syndrome in the region who do not respond to standard
therapy with intravenous ﬂuids, antibiotics, and supportive
care including inotropes.
2. Methods
We collected demographic data of all patients referred for
intensive care between January 2009 and June 2010 (18
months) and analyzed their outcomes in relation to the
complications of DSS that ensued during their ICU stay
and the therapies given. The diagnosis of Dengue has been
established upon clinical grounds (WHO guidelines 2009)
and treated accordingly by the referring physicians before
admission to the ICU. On admission to ICU, all have had
fever, vomiting 78%, abdominal pain 21%, cough 5%, and
body ache among 3% of cases. Eleven patients have had
serological tests and Dengue IgM was found to be positive
amongst 72% and IgG in 50% of the tested. They all have
had intravenous ﬂuid therapies and antibiotics. During the
courseoftherapyinICU,43.6%ofcasesreceivedfreshfrozen
plasma, 21.8% cryoprecipitate, 32.7% blood, and 56.4%
platelet transfusions. Furthermore, 36.4% of cases were
mechanically ventilated for multiple reasons such as severe
respiratory distress (FiO2 > 60%), RR > 40/min, myocardial
failure needing inotropes for persistent hypotension despite
adequate ﬁlling, that is, CVP above 12cm of H2O. The
decision for peritoneal dialysis was based on low urine
output (<0.5mL/kg/hour) detected over a period of time in
an ICU as a trend despite resuscitation with ﬂuids combined
with a situation of ﬂuid overload, high CVP, persistent
hypotension, or severe ARDS. Neither the plasma creatinine
(rather a delayed indicator of AKI) nor blood urea (not
reliable in the presence of liver impairment) was used as
a determining factor in implementing dialysis. Persistent
hypotension in the presence of high CVP was interpreted
as indication of myocardial involvement (with or without2 Journal of Tropical Medicine
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Figure 1: The cumulative age distribution of patients with Dengue
shock syndrome needing intensive care.
Table 1: Was the death early or late in ICU?
Day No. of deaths %
1 08 50%
2 03 19%
3 03 19%
5 01 06%
15 01 06%
Total 16 100%
relative bradycardia, ECG changes) and was supported with
inotropes, usually a combination of dobutamine and nor-
adrenaline and with mechanical ventilation if oxygenation
was compromised.. Thus, our data is based on a group of
severely ill patients diagnosed to be suﬀering from Dengue
Shock Syndrome and continuing to deteriorate despite
intravenoustherapiesadministeredinthewards.Liverfailure
regime, that is, oral/NG metronidazole and lactulose was
introduced in patients who were found to have raised
transaminases. It should be noted that the number of ICU
beds available (10) in our hospital was approximately 1.5%
of the total beds and this may have delayed the admission of
some cases due to rationing.
3. Results
Between January 2009 and June 2010, 54 cases (25 male)
diagnosed of Dengue Shock Syndrome were admitted for
treatment to the Peradeniya ICU, a tertiary referral center.
Half of them were aged 20 or below as shown in Figure 1.O n
admission, all had received prior intravenous ﬂuid therapies.
Their mean (SD) PCV was 44.5% (5.5), WBC 7.7×109/L
(4.6), Platelet count 22 109/L (17), respectively.
Of the 54, 16 died (mortality 29.6%). Most deaths (88%)
occurred within 3 days of admission to the ICU (Table 1).
The survivors needed intensive care for a median of 2 days
(range 1–8) before being discharged to the referring wards
for convalescence.
It is also noteworthy that 62.5% deaths occurred below
the age 20 (see Table 2). Although we were unable to prove
that risk of death was higher in children, a higher incidence
Table 2: Distribution of ICU deaths by age categories (∗1 missing
data).
Live discharges Deaths Total
≤20 years 16 10 26
>20 years 21 06 27
Total 37 16 53∗
χ2 = 1.66; df = 1; P = 0.198 (not signiﬁcant).
of deaths (38% as opposed to 22%) was observed below the
arbitrary cutoﬀ age of 20 years.
To evaluate the risk of death according to the mani-
festing complications we performed a bivariate analysis and
calculated the odds ratios (ORs) and conﬁdence intervals
(CI). OR and CI provide information on the strength
(level of statistical signiﬁcance) of association between the
complications and the occurrence of deaths. Whereever the
numbers of subjects were too small, the Fisher’s exact test
was used to calculate the P value (Table 3).
We found that the complications of Dengue, namely,
hemorrhage, pleural eﬀusion, myocarditis, liver failure, and
renal failure were independently linked with a 7–11 times
higher risk of death compared to those without (Table 3).
However, the wide conﬁdence intervals indicated the higher
variability of this observation.
The eﬀect of treatment modality on the outcome (death)
was evaluated with chi-square test (see Table 4). Chi-square
test is widely used to evaluate the association between these
predictor and outcome variables.
The results revealed that the treatment modalities,
namely, the use of inotropes, mechanical ventilation, peri-
toneal dialysis, and the use of blood products were signif-
icantly associated with higher occurrence of deaths among
these patients (Table 4). However, the use of steroids had no
association with death.
Thereafteradiscriminant analysiswasusedtoclassifythe
cases according to the values of categorical dichotomous-
dependent variables. This analysis assesses the relative im-
portance of the independent variables in classifying the
dependent variable.
Thestandardized canonicaldiscriminant functioncoeﬃ-
cients identiﬁed mechanical ventilation and peritoneal dial-
ysis as therapeutic modalities signiﬁcantly associated with
the deaths of dengue patients presenting with Dengue Shock
Syndrome (Table 5).
A similar discriminant analysis was used to assess the
relative importance of complications and outcome. Renal
failure and hemorrhage were identiﬁed as complications sig-
niﬁcantly associated with deaths in Dengue Shock Syndrome
(Table 6).
4. Discussion
We have evaluated the mortality risk factors amongst a
cross-section of patients in Dengue Shock Syndrome not
responding to standard therapies and as a consequence in
a clinical scenario confounded by previous therapies before
admission to ICU. Dengue Shock Syndrome is a dangerousJournal of Tropical Medicine 3
Table 3: Complications ensued and outcomes amongst patients with Dengue shock syndrome in ICU (∗Fisher’s exact test).
Complications Deaths Discharges Total OR CI P
Hemorrhage
Yes 13 14 27
7.4 1.8–30.7 0.003 No 3 24 27
Total 16 38 54
Pleural eﬀusion
Yes 13 14 27
7.4 1.8–30.7 0.003 No 3 24 27
Total 16 38 54
Myocarditis
Yes 8 6 14
5.3 1.4–19.8 0.02∗ No 8 32 40
Total 16 38 54
Yes 10 0 10
Renal failure No 06 38 44 <0.001∗
Total 16 38 54
Liver failure
Yes 08 03 11
11.7 2.2–54.1 0.001∗ No 08 35 43
Total 16 38 54
Table 4: Therapeutic modalities applied and outcomes of patients with Dengue Shock Syndrome receiving intensive care.
Therapies Deaths Discharges Total χ2 .df P
Inotropes
Yes 15 12 27
17.41 1 <0.001 No 01 26 27
Total 16 38 54
Mechanical ventilation
Yes 15 4 19
34.1 1 <0.001 No 1 34 35
Total 16 38 54
Liver failure regime
Yes 9 3 12
15.23 1 <0.001 No 7 35 42
Total 16 38 54
Peritoneal dialysis
Yes 8 0 8
22.3 1 <0.001 No 8 38 46
Total 16 38 54
Blood products
11 4 1 1 2 5
15.2 1 < 0.001 2 2 27 29
Total 16 38 54
Steroids
Yes 7 13 20
0.353 1 0.553 No 9 24 33
Total 16 37 53
complication of the dengue infection and is associated with
highmortality. Almostone-thirdofourstudygroupreceived
blood transfusions to counter their bleeding manifestations.
Thus, we were seeing the worst cases of the spectrum.
The pathogenesis of shock in dengue is complex. In-
creased vascular permeability, together with myocardial
dysfunction and dehydration due to capillary leakage, con-
tribute to the development of shock, with resultant multi-
organ failure. The onset of shock can be dramatic, and its
progression relentless. The diagnosis is largely clinical and
is supported by serology and identiﬁcation of viral material
in the blood. No speciﬁc methods are available to predict
outcome and progression. As observed by Singhi et al. [6]
the choice of ﬂuids, inotropes, and techniques of organ
support and careful ﬂuid management is the mainstay of
management.
We have recorded a 30% mortality risk for this unique
group of patients with Dengue Shock Syndrome who
had received prior medical therapies and was admitted to
Intensive Care with further deterioration. Unfortunately, the
fact that 50% of the patients who succumbed did so within
the ﬁrst 24 hours of admission to the ICU indicates their
moribund state upon referral to the ICU. It should be noted
that the presenting clinical status of these patients to the
ICU was confounded by a variety of treatment regimens
that were applied before admission to the ICU. For example,
in a typical patient admitted with respiratory distress and
hypoxia, the clinical picture would easily be modiﬁed by4 Journal of Tropical Medicine
Table 5: Standardized Canonical Discriminant functions between
therapeutic modalities and outcome (∗Wilk’s lambda = 0.315; df =
2; P<0.001).
Variables Canonical discriminant function
coeﬃcients
Mechanical ventilation 0.885∗
Peritoneal dialysis 0.566∗
Liver failure regime 0.474
Blood products 0.233
Steroids 0.215
Inotropes 0.192
Table 6: Standardized Canonical Discriminant functions between
complications and outcome.
Variables Canonical discriminant function
coeﬃcients
Renal failure .919∗
Liver failure .476
Pleural eﬀusion .417
Hemorrhage .377∗
Myocarditis .368
∗Wilk’s lambda = 0.419; df = 02; P<0.001.
overzealous hydration with colloids such as dextran or
hetastarch prior to the ICU referral. In this study we have not
been able to assess the inﬂuence of prior therapy on outcome
due to poor medical records received at the admission to
ICU. It is however the general impression of the authors,
that the inﬂuence of prior therapies could be an important
determinant of outcome, especially because some patients
were noted to have had a cumulative dose of hetastarch
exceeding 25mL/kg suggesting overload contributing to
respiratory distress more than the disease itself. This is a very
important aspect that cannot be overlooked in future studies
of this nature.
There is a general impression that fatal dengue is
commoner in the younger population compared to middle
or old age [7, 8]. Although we recorded 62.5% deaths
amongst patients aged 20 or below, we have no statistical
evidence to support the notion that mortality is higher
amongst children. This is because our age distribution also
indicated that 50% of the age cohort admitted for ICU care
was above the age of 20. Peradeniya ICU is multidisciplinary
and there are no age restrictions in its admission policy and
hence we presume that our data represent the population
with Dengue Shock Syndrome with no age bias.
Inourstudy,fromamongstthedead,88%expiredduring
ﬁrst three days of ICU care and the highest death rate
was reported on day 1 (50% of total deaths). A similar
study during an epidemic of dengue hemorrhagic fever in
easternmost Indonesia showed a case fatality rate of 1.2%
from a 172 suspected cases. They too observed that, the
survivors needed a range of 1–8 days of ICU care [9] similar
to the durations we observed. Another study from Mumbai
during a dengue epidemic reported a case fatality rate of
16.6% amongst pediatric patients suﬀering from Dengue
Shock syndrome [10].
Bleeding has been identiﬁed as one of the dreaded man-
ifestations of concern that complicates the outcome of
dengue [11]. Although our canonical discriminant analysis
indicatedthathemorrhageandrenalfailurewerethedreaded
complications associated with death, from amongst its main
therapeutic modalities only peritoneal dialysis (PD) was
associated with death. This suggested that the use of blood
products has eﬀectively mitigated the eﬀects of hemorrhage
upon outcome. However, peritoneal dialysis did not show
a similar eﬀect suggesting that PD may not be the most
appropriate modality of therapy in these moribund patients
with multiorgan failure. It is also our clinical observation
that PD cycles in Dengue patients produced a relatively large
ﬂuid retrieval without the use of additional measures such
as dextrose in dialysate ﬂuid. These large negative balances
were corrected with the use of stored plasma intravenously.
It is likely that these patients had ascites ﬂuid that was also
removed by each dialysis cycle and this may have simulated
the main problem of dengue, the “capillary leak.” Thus,
peritoneal dialysis may have aggravated the clinical eﬀects of
continuing “capillary leak” leading to worsened outcomes.
We had no facility for Continuous Renal Replacement
Therapy (CRRT).
We also found that mechanical ventilation was also
associated with death. Only 21% of patients who received
mechanical ventilation in the ICU recovered in this study (4
out of 19). Since we had no facility for ECMO, it is diﬃcult
to comprehend whether mechanical ventilation is the best
supportive mode of therapy to maintain oxygenation in DSS.
There was a signiﬁcant relationship between dengue,
complications, and the modes of therapies and outcome.
Hemorrhage, pleural eﬀusion, myocarditis, renal failure,
and liver failure were all important predictors of the worst
outcomes. A study conducted in Thailand implied the
importance of detection of abnormal high transaminase
enzyme among the patients with dengue infection since the
consequently developed hepatic encephalopathy could be
expected [12]. In our study 9 out of 12 patients who were
treated with liver failure regime expired (75%).
Dengue induced Acute Kidney Injury (AKI) comprising
creatinine increase, proteinuria, glomerulonephritis, and
haemolytic uremic syndrome has been reported [13, 14]
and also dengue-haemorrhagic-fever-(DHF-) induced AKI
even in the absence of shock, haemolysis, or rhabdomyolysis
[15]. In our study 8 out of 8 (100%) patients who were
suspected as having renal failure expired despite peritoneal
dialysis. Similar to our observation, Kuo et al. in the year
2002 reported a Dengue outbreak in Taiwan and noted that
patients with renal failure (RF) carry a high mortality rate,
that is, the morality rate RF group versus non-RF group was
28.6% against 1.2%; P<0.001 [16].
Acute reversible myocardial dysfunction is the com-
monest documented cardiac complication in dengue. The
variable incidences of dengue myocarditis had been postu-
lated to be due to variable immunopathogenesis secondary
to variations in serotypes. Dengue myocarditis is generally
reversible with favorable outcomes if diagnosed and treatedJournal of Tropical Medicine 5
early [17, 18]. In our study 15 out of 27 patients (55.55%)
who were suspected of having dengue myocarditis were
treated with inotropes but they died during their ICU stay.
It has been reported that corticosteroids were no more
eﬀective than the placebo or the no treatment protocol
for reducing the number of deaths, the need for blood
transfusion, or the number of serious complications [19]o r
in achieving a higher rise of the platelet count in dengue
infection [20]. We have observed the same. No speciﬁc
therapy has been shown to be eﬀective in improving survival
[21].
5. Conclusion
Our study indicates that during this dengue outbreak,
patients in DSS who were not responding to standard ther-
apies and admitted ICU had a 30% risk of death. Peritoneal
dialysis increases this risk to 100%.
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